PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.\', \'Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.\', \'Infectious Disease Unit and Laboratory, Chaim Sheba Medical Center, Ramat Gan, Israel.\', \'Galilee Medical Center, Nahariya, Israel.\', \'Department of Hematology, Rabin Medical Center-Beilinson Hospital, Petah Tikva, Israel.\', \'Department of Hematology, Ziv Medical Center, Safed, Israel.\', \'Department of Hematology, Kaplan Medical Center, Rehovot, Israel.\', \'Hadassah-Hebrew University Medical Center, Jerusalem, Israel.\', \'Hematology Unit, Bnai Zion Medical Center, Haifa, Israel.\', \'The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel; and.\', \'Hematology Division, Chaim Sheba Medical Center, Ramat-Gan, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1182/blood.2021014085
?:hasPublicationType
?:journal
  • Blood
is ?:pmid of
?:pmid
?:pmid
  • 34861036
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.434
?:rankingScore_hIndex
  • 410
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34861036>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34861036>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all